<DOC>
	<DOCNO>NCT02020954</DOCNO>
	<brief_summary>The purpose study determine whether electrocardiogram , echocardiography , cardiac MRI , serum biomarkers improve early detection myocardial involvement clinical outcome .</brief_summary>
	<brief_title>Prospective Becker-Heart-Study</brief_title>
	<detailed_description>A cohort 100 patient mutation dystrophin gene associate Becker muscular dystrophy and/or dilate cardiomyopathy include ( patient Duchenne muscular dystrophy exclude ) . Patients undergo baseline follow workups : electrocardiogram , echocardiography , cardiac MRI , serum biomarkers measurement . At 3 year 5 year , patient investigate accord protocol occurrence cardiac adverse event meanwhile record . Statistical analysis ass correlation cardiac phenotype DMD mutation prognostic value cardiac investigation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<criteria>mutation DMD gene Becker muscular dystrophy and/or dilate cardiomyopathy age &gt; 18 year affiliation French medical insurance Duchenne muscular dystrophy Any chronic disease may associate heart disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>